Abstract
The duplicated human α-globin structural loci lie on chromosome 16 and are arranged in the order 5′ α2−αl 3′. Although the most common molecular mechanism for α-thalassaemia is deletion of segments of DNA that contain one or both of these α-globin structural loci1, two molecular lesions that are not due to gross gene deletion have been defined. In one, a point mutation in the termination codon of the α2 gene results in the production of an elongated α-globin chain2,3. As only a small amount of the mutant globin chain is produced, α-thalassaemia results. The second lesion, which is caused by a 5-base pair (bp) deletion in the first intervening sequence of the α2 gene, results in abnormal mRNA processing and α-globin chain deficiency4. We now describe a novel mechanism for α-thalassaemia not involving deletion. A single nucleotide mutation in the coding region of the α2 gene results in the substitution of proline (Pro) for leucine (Leu) in a region of the H helix of the α-globin chain, which is critical for αl−βl contact. This probably impedes α1−β1 dimer formation, the initial step of haemoglobin tetramer assembly, and produces an α-thalassaemia phenotype.
Similar content being viewed by others
References
Weatherall, D. J. & Clegg, J. B. The Thalassaemia Syndromes 3rd edn (Blackwell Scientific, Oxford, 1981).
Milner, P. F., Clegg, J. B. & Weatherall, D. J. Lancet i, 729–732 (1971).
Michelson, A. M. & Orkin, S. H. Cell 22, 371–377 (1980).
Orkin, S. H., Goff, S. C. & Hechtman, R. L. Proc. natn. Acad. Sci. U.S.A. 78, 5041–5045 (1981).
Kan, Y. W., Dozy, A. M., Trecartin, R. & Todd, D. New Engl. J. Med. 297, 1080–1084 (1977).
Embury, S. H., Lebo, R. V., Dozy, A. M. & Kan, Y. W. J. clin. Invest. 63, 1307–1310 (1979).
Liebhaber, S. A. & Kan, Y. W. J. clin. Invest. 68, 439–446 (1981).
Chang, J. C. & Kan, Y. W. Lancet ii, 1127–1129 (1981).
Bunn, H. F., Forget, B. G. & Ranney, H. Human Hemoglobins (Saunders, Philadelphia, 1977).
Kleihauer, E. F. et al. Biochim. biophys. Acta 154, 220–222 (1968).
Vettore, L., DeMatteis, M. C. & Zampini, P. Am. J. Hemat. 8, 291–297 (1980).
Chang, J. C. & Kan, Y. W. Proc. natn. Acad. Sci. U.S.A. 76, 2886–2889 (1979).
Trecartin, R. F. et al. J. clin. Invest. 68, 1012–1017 (1981).
Polsky, F., Edgell, M. H., Seidman, J. G. & Leder, P. Analyt. Biochem. 87, 397–410 (1978).
Goodman, H. M. Meth. Enzym. 65, 63–64 (1980).
Blattner, F. R. et al. Science 196, 161–169 (1977).
Benton, W. D. & Davis, R. W. Science 196, 180–182 (1977).
Maxam, A. M. & Gilbert, W. Proc. natn. Acad. Sci. U.S.A. 74, 560–564 (1977).
Lauer, J., Shen, C-K. J. & Maniatis, T. Cell 20, 119–130 (1980).
Kan, Y. W., Schwartz, E. & Nathan, D. G. J. clin. Invest. 47, 2515–2522 (1968).
Alter, B. P. Blood 54, 1158–1163 (1979).
Lehmann, H. & Huntsman, R. G. Man's Haemoglobins, 449 (Lippincott, Philadelphia, 1974).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Goossens, M., Lee, K., Liebhaber, S. et al. Globin structural mutant α125Leu→Pro is a novel cause of α-thalassaemia. Nature 296, 864–865 (1982). https://doi.org/10.1038/296864a0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/296864a0
- Springer Nature Limited
This article is cited by
-
DNA studies are necessary for accurate patient diagnosis in compound heterozygosity for Hb Adana (HBA2:c.179>A) with deletional or nondeletional α-thalassaemia
Scientific Reports (2016)
-
α-thalassaemia
Orphanet Journal of Rare Diseases (2010)
-
Diversity in clinical presentation of hemoglobin H disease induced by the SEA deletion and the hemoglobin Quong Sze
Annals of Hematology (2009)
-
Clinical features and molecular analysis in Thai patients with HbH disease
Annals of Hematology (2009)
-
Hemoglobin H disease induced by the common SEA deletion and the rare hemoglobin Quong Sze in a Thai female: longitudinal clinical course, molecular characterization, and development of a PCR/RFLP-based detection method
Annals of Hematology (2007)